L Chauveinc

Summary

Affiliation: Institut Curie
Country: France

Publications

  1. ncbi [Indications for curietherapy of the prostate using permanent implants]
    L Chauveinc
    Departement de Radiotherapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 6:154-8. 2002
  2. pmc Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy
    L Chauveinc
    Radiotherapy Department, Institut Curie, 26 Rue d Ulm, 75248 Paris, Cedex 05, France
    Br J Cancer 89:2057-61. 2003
  3. ncbi PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup
    Alain Toledano
    Department of Oncology Radiotherapy, Institut Curie, Paris, France
    Brachytherapy 5:122-6. 2006
  4. ncbi Osteosarcoma following retinoblastoma: age at onset and latency period
    L Chauveinc
    Departement de Radiotherapie, Institut Curie, Paris, France
    Ophthalmic Genet 22:77-88. 2001
  5. ncbi [Update in radiation-induced neoplasms: genetic studies]
    Laurent Chauveinc
    Departement de Radiotherapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Bull Cancer 89:181-96. 2002
  6. ncbi [Brachytherapy of the prostatic cancer by interstitial permanent implantation of iodine-125]
    L Chauveinc
    Departement de Radiotherapie, Institut Curie, 26 Rue d Ulm, 75005 Paris, France
    Cancer Radiother 6:112-5. 2002
  7. ncbi Prostate cancer brachytherapy: is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institut Curie/Hospital Cochin (Paris) Group
    Laurent Chauveinc
    Department of Oncology Radiotherapy, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 59:691-5. 2004
  8. doi [Permanent implant prostate cancer brachytherapy: 2013 state-of-the art]
    J M Cosset
    Département d Oncologie Radiothérapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 17:111-7. 2013
  9. ncbi [CT and MR image fusion using two different methods after prostate brachytherapy: impact on post-implant dosimetric assessment]
    V Servois
    Département d Imagerie Médicale, Institut Curie, 26, rue d Ulm, 75005, Paris, France
    Cancer Radiother 7:9-16. 2003
  10. ncbi [Clinical and dosimetric analysis of 469 prostate cancer patients treated in France in 2005 by permanent implant brachytherapy using the Iodin 125 seeds IsoSeed Bebig: report to the French Economic committee of health products (CEPS)]
    J M Cosset
    Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 11:206-13. 2007

Collaborators

Detail Information

Publications24

  1. ncbi [Indications for curietherapy of the prostate using permanent implants]
    L Chauveinc
    Departement de Radiotherapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 6:154-8. 2002
    ..In conclusion, for adequately selected patients, brachytherapy offers a particularly applied alternative to surgery and external radiotherapy, with satisfactory long term biochemical control rates and limited complications...
  2. pmc Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy
    L Chauveinc
    Radiotherapy Department, Institut Curie, 26 Rue d Ulm, 75248 Paris, Cedex 05, France
    Br J Cancer 89:2057-61. 2003
    ..Perhaps reduction of doses of chemotherapy must be discussed for older patients...
  3. ncbi PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup
    Alain Toledano
    Department of Oncology Radiotherapy, Institut Curie, Paris, France
    Brachytherapy 5:122-6. 2006
    ....
  4. ncbi Osteosarcoma following retinoblastoma: age at onset and latency period
    L Chauveinc
    Departement de Radiotherapie, Institut Curie, Paris, France
    Ophthalmic Genet 22:77-88. 2001
    ..A radiation-induced mutation of the second RB1 allele may be the cause of osteosarcomas occurring after a short delay, while other genes may be affected in those occurring after a longer delay...
  5. ncbi [Update in radiation-induced neoplasms: genetic studies]
    Laurent Chauveinc
    Departement de Radiotherapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Bull Cancer 89:181-96. 2002
    ..But for the others, the differentiation is impossible to be done with cytogenetic. The mechanism of the chromosomic material losses in unknown, but some hypothesis are discussed...
  6. ncbi [Brachytherapy of the prostatic cancer by interstitial permanent implantation of iodine-125]
    L Chauveinc
    Departement de Radiotherapie, Institut Curie, 26 Rue d Ulm, 75005 Paris, France
    Cancer Radiother 6:112-5. 2002
  7. ncbi Prostate cancer brachytherapy: is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institut Curie/Hospital Cochin (Paris) Group
    Laurent Chauveinc
    Department of Oncology Radiotherapy, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 59:691-5. 2004
    ..The present study compared the two dosimetry data sets (US and CT) to evaluate how predictive extemporaneous US-based dosimetry can be of the real dose distribution...
  8. doi [Permanent implant prostate cancer brachytherapy: 2013 state-of-the art]
    J M Cosset
    Département d Oncologie Radiothérapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 17:111-7. 2013
    ....
  9. ncbi [CT and MR image fusion using two different methods after prostate brachytherapy: impact on post-implant dosimetric assessment]
    V Servois
    Département d Imagerie Médicale, Institut Curie, 26, rue d Ulm, 75005, Paris, France
    Cancer Radiother 7:9-16. 2003
    ..To study different methods of CT and MR images fusion in patient treated by brachytherapy for localized prostate cancer. To compare the results of the dosimetric study realized on CT slices and images fusion...
  10. ncbi [Clinical and dosimetric analysis of 469 prostate cancer patients treated in France in 2005 by permanent implant brachytherapy using the Iodin 125 seeds IsoSeed Bebig: report to the French Economic committee of health products (CEPS)]
    J M Cosset
    Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 11:206-13. 2007
    ..4%...
  11. ncbi [Brachytherapy for prostate cancer: old concept, new techniques]
    J M Cosset
    Departement de Radiotherapie, Institut Curie, 26, rue d Ulm, 75005 Paris
    Bull Cancer 93:761-6. 2006
    ....
  12. doi [Permanent implant prostate cancer brachytherapy]
    J M Cosset
    Département d oncologie et radiothérapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 12:503-11. 2008
    ..In spite of those drawbacks, with excellent long-term results and low rates of incontinence and impotence, brachytherapy can be expected to be proposed to an increasing number of patients in France in the next future...
  13. ncbi [Iodin 125 seed migration after prostate brachytherapy: a study of 170 patients]
    L Chauveinc
    Département d Oncologie Radiothérapie, Institut Curie, 26, rue d Ulm, 75005 Paris, France
    Cancer Radiother 8:211-6. 2004
    ..To study the number of migrating seeds, the anatomical site of migration and possible predictive parameters of migration, after prostate cancer brachytherapy using a loose-seed (I125) implantation technique...
  14. ncbi [Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]]
    D Nguyen
    Departement de Radiotherapie, Institut Curie, 26, rue d Ulm 75005 Paris, France
    Cancer Radiother 6:201-8. 2002
    ..Chemotherapy could also decrease metastatic recurrences. We report 92 cases of patients with locally advanced cervix cancer treated between 1986 and 1998 at the Institut Curie...
  15. ncbi Genome instability in secondary solid tumors developing after radiotherapy of bilateral retinoblastoma
    S H Lefèvre
    Institut Curie CNRS UMR 147, 26 Rue d Ulm, 75248 Paris Cedex 05, France
    Oncogene 20:8092-9. 2001
    ..In these predisposed patients, the loss of the single normal allele of RB1 is rather due to the radiation-induced chromosome instability than a direct effect of ionizing radiation...
  16. ncbi Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients
    Jean Marc Cosset
    Radiology Department, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 71:1042-8. 2008
    ..The aim of this study was to analyze overall and relapse-free survival in a cohort of 809 patients, 34% of whom corresponded to a higher-risk group than American Brachytherapy Society (ABS) criteria...
  17. ncbi Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study
    Catherine Buron
    Department of Medical Information, Institut Curie, Paris, France
    Int J Radiat Oncol Biol Phys 67:812-22. 2007
    ....
  18. ncbi Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases
    Michelle Fevre-Montange
    INSERM, U433, Fac Med RTH Laennec, Lyon, France
    J Neuropathol Exp Neurol 65:1004-11. 2006
    ..To conclude, the clinical course of PTPR is characterized by frequent local recurrence, and the value of radiotherapy on disease progression will need to be investigated in future prospective trials...
  19. ncbi Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer
    Thierry A Flam
    Department of Urology, Hopital Cochin, Paris, France
    J Urol 172:108-11. 2004
    ..We assessed the rate and results of transurethral resection of the prostate (TURP) in patients previously treated with brachytherapy as monotherapy for localized prostate cancer...
  20. ncbi Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results
    François Cornud
    Department of Radiology, Hopital Necker, Paris, France
    Radiology 224:203-10. 2002
    ..To identify the factor(s) most predictive of pT3 tumor and those most predictive of a positive endorectal magnetic resonance (MR) imaging result in patients with clinically localized prostate cancer...
  21. ncbi Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy
    Cecile Ortholan
    Department of Radiation Oncology, Centre Antoine Lacassagne, Nice, France
    Int J Radiat Oncol Biol Phys 62:479-85. 2005
    ..To investigate the clinical history, management, and pattern of recurrence of very early-stage anal canal cancer in a French retrospective survey...
  22. ncbi Specific TP53 mutation pattern in radiation-induced sarcomas
    Nathalie Gonin-Laurent
    UMR7147 Institut Curie CNRS UPMC, CEA LRC38, Paris, France
    Carcinogenesis 27:1266-72. 2006
    ..The lack of hyper-reactivity of CpG dinucleotides and the presence of recurrent sites of mutation at codons 135 and 237 seem also to be specific for radiation tumorigenesis...
  23. ncbi Non-homologous end-joining genes are not inactivated in human radiation-induced sarcomas with genomic instability
    Sandrine H Lefèvre
    Institut Curie CNRS UPMC UMR7147, CEA LRC38, Paris, France
    J Radiat Res 46:223-31. 2005
    ..Our findings suggest that non-homologous end-joining repair pathway alteration is unlikely to be involved in the high genomic instability observed in these tumors...
  24. ncbi [Nonsurgical treatment of chronic radiation-induced hemorrhagic proctitis]
    Vincent De Parades
    Service de Proctologie Médico Interventionnelle, Groupe Hospitalier Diaconesses Croix Saint Simon, F 75012 Paris, France
    Presse Med 37:1113-20. 2008
    ..Topical administrative of sucralfate or corticosteroids as well as argon plasma coagulation, with formalin treatment if necessary, provides relief for most patients...